300 Participants Needed

Text Message Intervention for Alcohol Consumption

(ASPIRE Trial)

BS
Overseen ByBrian Suffoletto, MD, MS
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This project aims to test the efficacy of a text message intervention, ASPIRE, designed to address cognitive and behavioral elements and modify exposure to peers that influence drinking behaviors. Young adults who are contemplating reducing their drinking will be recruited from a national sample and randomized to ASPIRE versus a text message intervention focused solely on cognitive and behavioral elements. We will measure effectiveness at 3, 6, and 12 months, study mechanisms driving behavior change, and identify which subgroups stand to benefit most.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does exclude those who are currently in treatment for alcohol or substance use disorder.

What data supports the effectiveness of the treatment ASPIRE for reducing alcohol consumption?

Research shows that supportive text messaging can help reduce alcohol consumption, as seen in studies where text messages improved outcomes for people with alcohol use disorder and those who have completed detoxification.12345

Is the text message intervention for alcohol consumption safe for humans?

Research on text message interventions for alcohol consumption suggests they are generally safe, as studies focus on their feasibility and acceptability without reporting significant safety concerns.678910

How is the ASPIRE text message treatment for alcohol consumption different from other treatments?

The ASPIRE text message treatment is unique because it uses mobile phone text messages to provide real-time, cost-effective support for reducing alcohol consumption, especially targeting younger adults and university students who may not seek traditional help. This approach is novel as it offers continuous, adaptive goal support in a non-intrusive way, unlike standard treatments that often require in-person sessions.1011121314

Research Team

BS

Brian Suffoletto, MD

Principal Investigator

Stanford University

Eligibility Criteria

The ASPIRE trial is for young adults aged 18-25 in the U.S. who want to cut down on drinking and own a mobile phone with SMS. They must read English and have had days in the past month with heavy drinking (4+ drinks for women, 5+ for men).

Inclusion Criteria

I live in the U.S.
I can read and understand English.
I own a mobile phone capable of sending and receiving texts.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive text message interventions designed to address cognitive, behavioral, and peer influences on drinking behaviors

12 months
Ongoing virtual engagement through text messages

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

Treatment Details

Interventions

  • ASPIRE
Trial Overview ASPIRE tests a text message intervention aimed at reducing alcohol consumption by addressing how thinking, behavior, and peers influence drinking. Participants are randomly assigned to ASPIRE or a control group focusing only on cognitive and behavioral aspects.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: A text message alcohol intervention focused on cognitive, behavioral, and peer influencesExperimental Treatment1 Intervention
Group II: A text message alcohol intervention focused on cognitive and behavioral influencesActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Findings from Research

In a study of 54 participants with depression and alcohol use disorder, those receiving supportive text messages showed significantly lower depression scores after three months compared to the control group, indicating improved mood.
While the text message group also tended to have longer periods of abstinence from alcohol, the difference was not statistically significant, suggesting that supportive messaging may help but further research is needed.
Supportive text messaging for depression and comorbid alcohol use disorder: single-blind randomised trial.Agyapong, VI., Ahern, S., McLoughlin, DM., et al.[2022]
A 1-year SMS intervention significantly reduced heavy drinking among 462 patients with alcohol dependence after detoxification, with 22.2% in the intervention group compared to 32.3% in the treatment as usual group.
The SMS intervention showed an odds ratio of 1.68 for reducing heavy drinking, indicating it was effective in promoting better drinking outcomes compared to standard treatment alone.
Effect of a 1-year short message service in detoxified alcohol-dependent patients: a multi-center, open-label randomized controlled trial.Lucht, M., Quellmalz, A., Mende, M., et al.[2021]
A study involving 59 patients with alcohol use disorder showed that supportive text messaging after treatment can significantly extend the time before a patient has their first drink, with the intervention group averaging about 60 days compared to 26 days for the control group.
The text messaging intervention also demonstrated small to moderate improvements in cumulative abstinence duration and alcohol consumption, indicating it could be a valuable follow-up care tool for patients after residential treatment.
Randomized controlled pilot trial of supportive text messaging for alcohol use disorder patients.Agyapong, VIO., Juhรกs, M., Mrklas, K., et al.[2019]

References

Supportive text messaging for depression and comorbid alcohol use disorder: single-blind randomised trial. [2022]
Effect of a 1-year short message service in detoxified alcohol-dependent patients: a multi-center, open-label randomized controlled trial. [2021]
Randomized controlled pilot trial of supportive text messaging for alcohol use disorder patients. [2019]
A Randomized Controlled Pilot Trial of Different Mobile Messaging Interventions for Problem Drinking Compared to Weekly Drink Tracking. [2022]
A pilot study on the feasibility and acceptability of a text message-based aftercare treatment programme among alcohol outpatients. [2015]
Delivering Personalized Protective Behavioral Drinking Strategies via a Smartphone Intervention: a Pilot Study. [2020]
Automated, tailored adaptive mobile messaging to reduce alcohol consumption in help-seeking adults: A randomized controlled trial. [2023]
Perception of patients with alcohol use disorder and comorbid depression about the usefulness of supportive text messages. [2015]
Comment on the paper by Suffoletto et al. entitled: Text-message-based assessments and brief intervention for young adults discharged from the emergency department. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Text message reminders as an adjunct to a substance use intervention for adolescents and young adults: Pilot feasibility and acceptability findings. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
The Effectiveness of Mobile Phone-Based Text Messaging to Intervene with Problem Drinking in Youth and Younger Adult Population: A Meta-Analysis. [2021]
A Text Message-Based Intervention Targeting Alcohol Consumption Among University Students: User Satisfaction and Acceptability Study. [2023]
A Text Message Intervention with Adaptive Goal Support to Reduce Alcohol Consumption Among Non-Treatment-Seeking Young Adults: Non-Randomized Clinical Trial with Voluntary Length of Enrollment. [2020]
A surveillance tool using mobile phone short message service to reduce alcohol consumption among alcohol-dependent patients. [2017]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity